DeutschNewstral
Article
CNN on 2023-11-08 20:03
FDA approves Eli Lilly's diabetes drug Mounjaro for obesity under new name, Zepbound
Related news
Eli Lilly weight loss drug Zepbound approved by the FDANew York Post- MEli Lilly Zepbound, Mounjaro obtainable after shortages, FDA saysmvtelegraph.com
New weight loss drug: FDA approves Zepbound, a version of diabetes drug Mounjaro for obesitySan Jose Mercury News
Eli Lilly starts website to connect patients with new obesity treatment, Zepbound, other drugsSeattle Times
FDA Approves Diabetes Drug Mounjaro For Weight Loss Under Brand Name ZepboundForbes- MEli Lilly's Emgality gets FDA approval for episodic cluster headachesmarketwatch.com
- MEli Lilly expects FDA name on Zepbound for sleep apnea in close to time periodmvtelegraph.com
Eli Lilly raises price of Zepbound while trumpeting discount on starter vialsArs Technica- IFDA fast tracks Eli Lilly’s obesity drug: ‘this is the Holy Grail’invezz.com
- Weight-Loss Drugs Dangers Explained: Zepbound, Mounjaro Maker Warn Of Coming Counterfeit LawsuitForbes
Eli Lilly wins FDA nod for obesity drug that rivals Wegovy, Ozempic - Wed, 08 Nov 2023 PSTsyndication.washingtonpost.com
Eli Lilly's COVID treatment gets emergency use authorizationisraelnationalnews.com- MLilly's ambitious new drug Mounjaro fails to impress in the fourth quarter3 min readmarketwatch.com
- TPfizer stock leaps on obesity drug challenge to Ozempic, Zepboundthestreet.com
- DEli Lilly slumps after disappointing Zepbound weight-loss-drug trialdcourier.com
- MEli Lilly's stock rallies after BMO raises rating, price targetmarketwatch.com
Eli Lilly's Alzheimer's Drug Shows Promise in Small TrialThe New York Times- MEli Lilly sues clinics allegedly promoting knockoff variations of Mounjaromvtelegraph.com
- Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, MounjaroSeattle Times
- Eli Lilly Surges On Strong Earnings As Mounjaro And Zepbound Sales SoarForbes